Pitney Bowes Shares Drop As Q2 Earnings Falls Short
Pitney Bowes Inc (NYSE:PBI) reported a second-quarter FY22 sales decline of 3.1% year-on-year to $871.5 million, missing the analyst consensus of…
Google Delaying Phasing Out Of Third-Party Cookies On Chrome Will Benefit These Companies, Analysts Say
Earlier today, Alphabet Inc (NASDAQ: GOOG) (NASDAQ: GOOGL) Google announced delaying the phase-out of third-party cookies on Chrome until 2H24, an ~ one-year extension from its initial plan.
U.S. Stocks Turn Higher, Dow Surges More Than 200 Points
U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 200 points on Thursday.
Ayurcann To Launch New Cannabis Products, Grants Restricted Share Units
Ayurcann Holdings Corp (OTCQB: AYURF) (CSE:AYUR) (FSE:3ZQ0) has been working with provincial boards across Canada and has been rewarded with new SKUs coming to market over the next three months in high potency distillate vapes, concentrates
Daily Biotech Pulse: GSK’s Kidney Disease Drug Approved For Children, Tonix Pharma To Launch Monkeypox Vaccine Study In Kenya, Positive Effect Of Cyclerion’s Schizophrenia Candidate
Here's a roundup of top developments in the biotech space over the last 24 hours:
Canada-Based Project Solace Aims To Provide Access And Data On Medical Psilocybin
TheraPsil, a Canadian coalition for psilocybin therapy legalization, together with the U.K. independent foundation Drug Science, has launched Project Solace.
Canopy Growth’s 7ACRES And Doja Launching New Cannabis Products
Canopy Growth Corporation (NASDAQ: CGC) (TSX:WEED) is releasing a range of new, premium flower offerings throughout the summer from 7ACRES and Doja.
Lifeist Q2 2022 Revenue Decreases 15% YoY, Here Are The Details
Lifeist Wellness Inc.’s (OTCQB: NXTTF) (TSXV:LFST) (FRANKFURT:M5B) net revenue decreased 15% to CA$4.1 million ($3.19 million) in Q2 2022 compared to CA$4.9 million in Q2 2021.
Tilray’s Fiscal 2022 Revenue Grows 22% YoY, Here Are The Details
Tilray Brands, Inc. (NASDAQ: TLRY) (TSX:TLRY) net revenue grew 8% to $153.3 million during the fourth quarter 2022, from $142.2 million in the prior year quarter.